Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Refines subtype distinction in lipid disorders; leaves open whether targeted interventions alter long-term outcomes.
Type II Hyperlipoproteinemia159, 192 193 194 195 196 General Definitions. By the Type II lipoprotein pattern we mean an increase in the concentration of lipoproteins that have discrete β mobility by electrophoresis and the normal density and chemical composition of β-migrating lipoproteins. This kind of hyperbeta-lipoproteinemia must be distinguished from another in which the density of the β-migrating lipoproteins is abnormally low, giving rise to a pattern designated as Type III in this system for defining types of hyperlipoproteinemia. The bases for distinguishing the hyperbeta-lipoproteinemia of Types II and III arise from considerable clinical and genetic evidence that they are expressions of different inheritable . . .
No takes yet. Share an insight, caveat, or question.
Fredrickson et al. (1967) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: